The Warriedar story just keeps getting better., page-104

First 104 Last

Share
Profile

Follow
Joelstar

3,954 Posts.

2639

10/05/24

22:41

Post #: 73772583
Share

Originally posted by speculator101: ↑

Well done Joel, without a doubt, the producers overall took a large breather (except for RED/SLR).
WA8 has been the best performer in regards to my small selection of explorers (SPR is sort of a hybrid).
Whoa... wait.... AAR just won. I had not even looked at it

For better or worse, I am continuing to stick with producers overall, though ones with less hedging (for more torque).

As for GBR & ROX, both logical and arguably good for a trade, though both have.... hmm.. issues so to speak.
ROX is going to need something to change it's spots, otherwise it will continue to be hated.
GBR is just slow

Though I note a few on your list are very.... for me, high risk, but I can understand from a trading perspective, great due to their low volumes and being potentially swept up with the sector overall.

I owe you a drink at the next conference, as WA8 has done very well over a short period of time (though I think extremely undervalued even now).

Interesting move in POG right now.

Expand

Really looking forward to catching up for that beer Spec.
ROX is a bit of a turd of a stock but even the ugly stepchildren catchup in a hot gold market.
GBR is slow and steady but ticks a lot of boxes.
They'll probably need to raise again within the next 3 months.

Here's the producer's weekly table for comparison (up 4%).
Do you have any idea what is going on with CMM?
It really underperformed this week.

WA8 Price at posting: 6.3¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement